• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Crit Care Resusc. Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study

tetano

Editor, Senior Moderator
Crit Care Resusc. 2020 Apr 6. [Epub ahead of print]
Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study


Ling L[SUP]1[/SUP], So C[SUP]2[/SUP], Shum HP[SUP]3[/SUP], Chan PKS[SUP]4[/SUP], Lai CKC[SUP]4[/SUP], Kandamby DH[SUP]5[/SUP], Ho E[SUP]5[/SUP], So D[SUP]5[/SUP], Yan WW[SUP]3[/SUP], Lui G[SUP]6[/SUP], Leung WS[SUP]7[/SUP], Chan MC[SUP]7[/SUP], Gomersall CD[SUP]8[/SUP].

Author information




Abstract

Objective:

To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes.
Design:

Multicentre retrospective observational cohort study.
Setting:

Three multidisciplinary intensive care units (ICUs) in Hong Kong.
Participants:

All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020.
Main outcome measure:

28-day mortality.
Results:

Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42–70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4–7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days.
Conclusion:

Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness.



PMID:32248675
 
Back
Top